Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02118935 · ClinicalTrials.gov registry record · NA
Nutritive Effects of Prebiotics on Early Postnatal Behavioral Measures of Tolerance
A NA study, sponsored by Mead Johnson Nutrition.
- Completed
- Registry status
- NA
- Development phase
- 161
- Enrollment target
NCT02118935: Completed NA study, sponsored by Mead Johnson Nutrition.
NCT02118935 is a NA study that has completed, run by Mead Johnson Nutrition. The registered enrollment target is 161 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02118935, a NA study, has completed, sponsored by Mead Johnson Nutrition.
- COMPLETED
- Registry status
- NA
- Development phase
- 161 participants
- Enrollment target
Study Summary
The study is intended to measure infant comfort, behavior, and sleep when consuming study formula with prebiotics compared to infants who consume a study formula without the prebiotics.
Interventions
- OTHER Previously marketed cow's mlik-based infant formula
- OTHER Marketed cow's milk-based infant formula with prebiotics
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2014-04 |
| Est. Completion | 2016-03 |
| Phase | NA |
What the finished NCT02118935 record still lists
NCT02118935 is an interventional study that assigns participants to a tested intervention. The registered 161 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which Previously marketed cow's mlik-based infant formula is the first listed.
NCT02118935 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02118935 about?
NCT02118935 is a clinical study titled "Nutritive Effects of Prebiotics on Early Postnatal Behavioral Measures of Tolerance". The study is intended to measure infant comfort, behavior, and sleep when consuming study formula with prebiotics compared to infants who consume a study formula without the prebiotics.
What is the current status of trial NCT02118935?
This trial is currently completed. It is a NA study. The enrollment target is 161 participants. The study started on 2014-04. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02118935?
The interventions under investigation include: Previously marketed cow's mlik-based infant formula (OTHER), Marketed cow's milk-based infant formula with prebiotics (OTHER).
Who is sponsoring clinical trial NCT02118935?
This trial is sponsored by Mead Johnson Nutrition, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02118935's enrollment target sits among peer trials
161 628th of 2000 higher than 1,373 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06391034 · 161 participants · Phase 2
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
- NCT06546670 · 161 participants · Phase 1
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
- NCT06616766 · 161 participants · Phase 1
A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946
- NCT06752356 · 161 participants · Phase 3
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia